CAS No |
Product Name |
Molecular Formula |
166599-84-4
|
4-Benzofurancarboxylic acid;1-Benzofuran-4-carboxylic acid
|
C9H6O3
|
166663-25-8
|
Anidulafungin;N-((3S,6S,9S,11R,15S,18S,20R,21R,24S,25S,26S)-6-((1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl)-11,20,21,25-tetrahydroxy-3,15-bis((1R)-1-hydroxyethyl)-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo(22.3.0.09,13)heptacosan-18-yl)-4-(4-(4-pentoxyphenyl)phenyl)benzamide
|
C58H73N7O17
|
166672-22-6
|
5-Benzyloxy-2-cyanopyrimidine
|
C12H9N3O
|
166735-51-9
|
Benzyl [(2R)-1-Hydroxy-4-Methyl-2-Pentanyl]Carbamate
|
C14H21NO3
|
166737-85-5
|
S-Trityl-L-cysteinamide hydrochloride;H-Cys(Trt)-NH2.HCl; (R)-2-Amino-3-(tritylthio)propanamide hydrochloride
|
C22H22N2OS.HCl
|
166744-78-1
|
4-Benzyloxy-2-fluorophenylboronic acid
|
C13H12BFO3
|
166764-19-8
|
(2R)-(-)-1,1-Bis(4-methoxyphenyl)-3-methyl-1,2-butanediamine
|
C19H26N2O2
|
166770-70-3
|
2-Chloro-4-(trifluoromethyl)-3-pyridinamine
|
C6H4ClF3N2
|
166773-08-6
|
1,3,4-Triphenyl-4,5-dihydro-1H-1,2,4-triazol-5-ylidene
|
C20H15N3
|
166815-96-9
|
4-(((4-Tolylsulfonyl)oxy)methyl)piperidine-1-carboxylic acid tert-butyl ester;N-(tert-Butoxycarbonyl)-4-(tosyloxymethyl)piperidine; N-tert-Butoxycarbonyl-4-(4-toluenesulfonyloxymethyl)piperidine; N-tert-Butoxycarbonyl-4-(4-toluenesulphonyloxymethyl)piperidine; tert-Butyl 4-(tosyloxymethyl)piperidine-1-carboxylate
|
C18H27NO5S
|
166821-88-1
|
2-[2-(Bromomethyl)Phenyl]-5,5-Dimethyl-1,3,2-Dioxaborinane
|
C12H16BBrO2
|
166827-53-8
|
(E,E)-4,4'-Bis(2-(4-methoxyphenyl)ethenyl)-2,2'-bipyridine
|
C28H24N2O2
|
166831-65-8
|
2,2,2-Trifluoro-1-[2-(Methylsulfanyl)Phenyl]Ethanone
|
C9H7F3OS
|
166881-42-1
|
N-((2,4-Dimethoxyphenyl)methyl)-N-((9H-fluoren-9-ylmethoxy)carbonyl)glycine
|
C26H25NO6
|
166881-43-2
|
N-((9H-Fluoren-9-ylmethoxy)carbonyl)-N-((2,4,6-trimethoxyphenyl)methyl)glycine
|
C27H27NO7
|
166883-00-7
|
Methyl (2E)-3-(2,4-Difluorophenyl)Acrylate
|
C10H8F2O2
|
166883-20-1
|
2,3-Dihydro-1-Methyl-2-Oxo-1H-Indole-5-Sulfonylchloride
|
C9H8ClNO3S
|
166897-40-1
|
Ferric oxalate hexahydrate;Iron(III) oxalate hexahydrate
|
C6Fe2O12.6(H2O)
|
166943-39-1
|
N-Methyl-4-nitrophenethylamine hydrochloride;N-Methyl-2-(4-nitrophenyl)etnylamine hydrochloride
|
C9H12N2O2.HCl
|
166947-09-7
|
4-(Trifluoromethyl)benzenepropanal;3-(4-Trifluoromethylphenyl)propanal; 3-(4-Trifluoromethylphenyl)propionaldehyde
|
C10H9F3O
|
166953-64-6
|
Benzyl 4-bromopiperidine-1-carboxylate;4-Bromopiperidine-1-carboxylic acid benzyl ester; 4-Bromo-N-Cbz-piperidine
|
C13H16BrNO2
|
166964-09-6
|
4-Chloro-3-methyl-5-isoxazolamine
|
C4H5ClN2O
|
166964-26-7
|
2,5-Dimethyl-3-Furansulfonylchloride
|
C6H7ClO3S
|
166964-31-4
|
5-[1-Methyl-5-(Trifluoromethyl)-1H-Pyrazol-3-Yl]-2-Thiophenesulfonyl Chloride
|
C9H6ClF3N2O2S2
|
166964-33-6
|
5-Chloro-3-Methylbenzo[b]Thiophene-2-Sulfonyl Chloride
|
C9H6Cl2O2S2
|
166964-35-8
|
4-Bromo-5-Chlorothiophene-2-Sulphonyl Chloride
|
C4HBrCl2O2S2
|
166964-36-9
|
4-Bromo-2,5-Dichloro-3-Thiophenesulfonylchloride
|
C4BrCl3O2S2
|
166964-37-0
|
5-(Phenylsulfonyl)-2-Thiophenesulfonylchloride
|
C10H7ClO4S3
|
166975-76-4
|
4-(2-Piperidinoethoxy)benzoic acid hydrochloride
|
C14H19NO3.HCl
|
166977-43-1
|
4-((1E)-2-(5,6-Dihydro-5,5-dimethyl-8-phenyl-2-naphthalenyl)ethenyl)benzoic acid;BMS 189453; BMS 453
|
C27H24O2
|
166978-46-7
|
7-Bromo-4,4-dimethyl-1-tetralone
|
C12H13BrO
|
167015-11-4
|
N-Fmoc-S-trityl-D-cysteine;N-(9-Fluorenylmethoxycarbonyl)-S-trityl-D-cysteine; Fmoc-D-Cys(Trt)-OH
|
C37H31NO4S
|
167015-23-8
|
N-Fmoc-S-trityl-L-homocysteine;Fmoc-Hcys(Trt)-OH; (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-4-(tritylthio)butanoic acid
|
C38H33NO4S
|
167015-84-1
|
3-(2-Aminoethyl)-1H-indole-1-carboxylic acid 1,1-dimethylethyl ester
|
C15H20N2O2
|
167026-90-6
|
(1Z)-1,2,3,4,4,4-Hexafluoro-1-Iodo-3-(Trifluoromethyl)-1-Butene
|
C5F9I
|
167027-30-7
|
6-Amino-1H-indole-2-carboxylic acid methyl ester
|
C10H10N2O2
|
167073-07-6
|
(1S,2R)-2-Fluorocyclopropanecarboxylic acid
|
C4H5FO2
|
167073-08-7
|
(1R-trans)-2-Fluorocyclopropanecarboxylic acid
|
C4H5FO2
|
167073-19-0
|
Pitavastatin ethyl ester;(3R,5S(E))-Ethyl 7-(2-cyclopropyl-4-(p-fluorophenyl)quinolin-3-yl)-3,5-dihydroxy-6-heptenoate
|
C27H28FNO4
|
167081-25-6
|
tert-Butyl (cis-4-hydroxycyclohexyl)carbamate;cis-(4-Hydroxycyclohexyl)carbamic acid tert-butyl ester; cis-4-(tert-Butoxycarbonylamino)cyclohexanol; tert-Butyl N-(cis-4-hydroxycyclohexyl)carbamate
|
C11H21NO3
|
167081-37-0
|
tert-Butyl (trans-3-hydroxymethylcyclobutyl)carbamate
|
C10H19NO3
|
167102-62-7
|
2-Methyl-2-Propanyl (4R)-4-[Methoxy(Methyl)Carbamoyl]-2,2-Dimethyl-1,3-Oxazolidine-3-Carboxylate
|
C13H24N2O5
|
167105-80-8
|
Ketorolac EP Impurity E;5-benzoyl-N-(1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl)-2,3-dihydro-1H-pyrrolizine-1-carboxamide
|
C19H22N2O5
|
167114-91-2
|
L-Lysyl-L-Lysyl-L-Alanyl-L-Leucyl-L-Arginyl-L-Arginyl-L-Glutaminyl-L-alpha-Glutamyl-L-Alanyl-L-Valyl-L-alpha-Aspartyl-L-Alanyl-L-Leucine
|
C64H115N22O19
|
167145-13-3
|
2-(2-(3-Methoxyphenyl)ethyl)phenol
|
C15H16O2
|
167158-70-5
|
6-Bromo-2-chloro-4(3H)-quinazolinone
|
C8H4BrClN2O
|
167218-30-6
|
N,N,N'-Triphenyl-(1,1'-biphenyl)-4,4'-diamine;N-(4-(Diphenylamino)-1,1'-biphenyl-4'-yl)phenylamine
|
C30H24N2
|
167218-46-4
|
N,N'-Bis(4'-(diphenylamino)(1,1'-biphenyl)-4-yl)-N,N'-diphenyl-(1,1'-biphenyl)-4,4'-diamine;TPTE
|
C72H54N4
|
167221-71-8 / 166432-28-6
|
Cleviprex;Clevidipine butyrate; 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-Pyridinedicarboxylic acid methyl (1-oxobutoxy)methyl ester
|
C21H23Cl2NO6
|
167223-43-0
|
3-Methyl-D-valine methyl ester hydrochloride
|
C7H15NO2.HCl
|